Numinus Wellness, Inc. (NUMIF)
0.0278
-0.01
(-17.75%)
USD |
OTCM |
Sep 08, 16:00
Numinus Wellness Shareholders Equity (Quarterly) : -2.815M for May 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -2.815M |
| February 28, 2026 | -2.613M |
| November 30, 2025 | -2.440M |
| August 31, 2025 | -2.316M |
| May 31, 2025 | -1.131M |
| February 28, 2025 | -0.5665M |
| November 30, 2024 | -0.3693M |
| August 31, 2024 | 0.5735M |
| May 31, 2024 | 3.398M |
| February 29, 2024 | 7.436M |
| November 30, 2023 | 7.454M |
| August 31, 2023 | 10.38M |
| May 31, 2023 | 16.56M |
| February 28, 2023 | 21.64M |
| November 30, 2022 | 26.74M |
| August 31, 2022 | 31.47M |
| May 31, 2022 | 34.72M |
| February 28, 2022 | 39.56M |
| November 30, 2021 | 43.88M |
| August 31, 2021 | 48.14M |
| May 31, 2021 | 55.51M |
| February 28, 2021 | 25.72M |
| November 30, 2020 | 4.702M |
| August 31, 2020 | 2.149M |
| May 31, 2020 | 4.082M |
| Date | Value |
|---|---|
| January 31, 2020 | 0.4331M |
| October 31, 2019 | -0.0003M |
| July 31, 2019 | -0.0415M |
| April 30, 2019 | 0.0155M |
| January 31, 2019 | -0.1121M |
| October 31, 2018 | -0.0754M |
| July 31, 2018 | -0.0617M |
| April 30, 2018 | 0.0205M |
| January 31, 2018 | 0.0291M |
| October 31, 2017 | 0.0925M |
| July 31, 2017 | 0.0798M |
| April 30, 2017 | 0.0639M |
| January 31, 2017 | 0.0015M |
| October 31, 2016 | 0.0467M |
| July 31, 2016 | 0.087M |
| April 30, 2016 | 0.0107M |
| January 31, 2016 | 0.0382M |
| October 31, 2015 | 0.0779M |
| July 31, 2015 | 1.486M |
| April 30, 2015 | 1.532M |
| January 31, 2015 | 1.165M |
| October 31, 2014 | 1.370M |
| July 31, 2014 | 1.457M |
| April 30, 2014 | 1.401M |
| January 31, 2014 | 1.135M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 1.044M |
| Edesa Biotech, Inc. | 8.811M |
| CNBX Pharmaceuticals, Inc. | -2.660M |
| GB Sciences, Inc. | -- |
| Invion Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.852M |
| Total Liabilities (Quarterly) | 4.668M |
| Debt to Equity Ratio | -0.4102 |
| Current Ratio | 0.3101 |
| Net Debt Paydown Yield | 1.63% |